โครเอเชีย - โครเอเชีย - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid d.o.o., slavonska avenija 6 a, zagreb, hrvatska - cefuroksimnatrij - prašak za otopinu za injekciju / infuziju - 750 mg - urbroj: jedna bočica sadrži 750 mg cefuroksima u obliku cefuroksimnatrija

โครเอเชีย - โครเอเชีย - HALMED (Agencija za lijekove i medicinske proizvode)

apta medica internacional d.o.o., likozarjeva ulica 6, ljubljana, slovenija - cefuroksimnatrij - prašak za otopinu za injekciju / infuziju - 1500 mg - urbroj: jedna bočica sadrži 1578 mg cefuroksimnatrija što odgovara 1500 mg cefuroksima.

โครเอเชีย - โครเอเชีย - HALMED (Agencija za lijekove i medicinske proizvode)

apta medica internacional d.o.o., likozarjeva ulica 6, ljubljana, slovenija - cefuroksimnatrij - prašak za otopinu za injekciju / infuziju - 750 mg - urbroj: jedna bočica sadrži 789 mg cefuroksimnatrija što odgovara 750 mg cefuroksima.

บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

nobel lijek d.o.o. sarajevo - cefuroksim - prašak i rastvarač za rastvor za injekciju/infuziju - 750 mg/1 bočica - 1 bočica sa praškom za rastvor za injekciju/infuziju sadrži: 750 mg cefuroksima (u obliku cefuroksimnatrijuma)

บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

unifarm d.o.o. lukavac - cefuroksim - prašak i rastvarač za rastvor za injekciju/infuziju - 750 mg/1 bočica - 1 bočica sa praškom za rastvor za injekciju/infuziju sadrži: 750 mg cefuroksima u obliku cefuroksim natrija

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastična sredstva - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - svi ostali terapeutski proizvodi - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

สหภาพยุโรป - โครเอเชีย - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - multipli mijelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pharmavision bh d.o.o. - cefuroksim - prašak za rastvor za injekciju ili infuziju - 1500 mg/1 bočica - 1 bočica praška za rastvor za injekciju ili infuziju sadrži 1500 mg cefuroksima (što odgovara 1578 mg cefuroksim natrijuma)

บอสเนียและเฮอร์เซโกวีนา - โครเอเชีย - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pharmavision bh d.o.o. - cefuroksim - prašak za rastvor za injekciju ili infuziju - 750 mg/1 bočica - 1 bočica praška za rastvor za injekciju ili infuziju sadrži 750 mg cefuroksima (što odgovara 789 mg cefuroksim natrijuma).